Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Short-term Investments (2017 - 2022)

Historic Short-term Investments for cbdMD (YCBD) over the last 6 years, with Q4 2022 value amounting to $1.0 million.

  • cbdMD's Short-term Investments changed 0.0% to $1.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2022, which is 0.0% changed from last year.
  • Latest data reveals that cbdMD reported Short-term Investments of $1.0 million as of Q4 2022, which was down 0.0% from $1.0 million recorded in Q3 2022.
  • Over the past 5 years, cbdMD's Short-term Investments peaked at $3.2 million during Q1 2018, and registered a low of $52527.0 during Q2 2020.
  • Over the past 5 years, cbdMD's median Short-term Investments value was $1.0 million (recorded in 2021), while the average stood at $1.2 million.
  • In the last 5 years, cbdMD's Short-term Investments plummeted by 9742.42% in 2020 and then skyrocketed by 182931.64% in 2021.
  • Over the past 5 years, cbdMD's Short-term Investments (Quarter) stood at $1.9 million in 2018, then crashed by 60.78% to $736527.0 in 2019, then plummeted by 62.09% to $279181.0 in 2020, then soared by 258.19% to $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022.
  • Its Short-term Investments stands at $1.0 million for Q4 2022, versus $1.0 million for Q3 2022 and $1.0 million for Q2 2022.